THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ZACKS INVESTMENT MANAGEMENT's Holding History (CIK: 0001086483)

Note: Option positions (PUT/CALL) are excluded.

Q2 2017

Shares 21,603 Value ($000) $861 Avg Close $38.45 Range $34.85 - $43.44

Q1 2017

Shares 20,644 Value ($000) $760 Avg Close $31.95 Range $27.80 - $37.18

Q4 2016

Shares 12,248 Value ($000) $390 Avg Close $31.02 Range $24.54 - $38.92

Q3 2016

Shares 6,665 Value ($000) $242 Avg Close $27.84 Range $21.97 - $37.14

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2017	21,603	$861	$38.45	$34.85 - $43.44
Q1 2017	20,644	$760	$31.95	$27.80 - $37.18
Q4 2016	12,248	$390	$31.02	$24.54 - $38.92
Q3 2016	6,665	$242	$27.84	$21.97 - $37.14